Case Study

Enhancing Pharmacokinetics Workflows at Charles River

PreclinicalPhoenix™ Integral Data Repository Charles River, a global leader in drug development, sought to improve…

CertaraNovember 13, 2024

Blog

PBPK modeling to support bioequivalence & generic product approvals

Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…

CertaraNovember 12, 2024

Publication

Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody

The article titled "Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a…

CertaraNovember 4, 2024

On-Demand Webinar

On-ramps to popPK: Building Better Models with GUI, Code, or Both

A critical component of popPK studies is popPK modeling, where mathematical models are developed to…

CertaraOctober 18, 2024

Fact Sheet

Certara University: Grow as a PK/PD Scientist

CertaraOctober 16, 2024

Conference

16th Annual World ADC London 2026

CertaraOctober 11, 2024

Publication

Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator

The article "Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system…

CertaraAugust 26, 2024

Publication

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

The article “Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL)…

CertaraAugust 26, 2024

Publication

A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator

This collaborative effort by Certara and the Centre for Applied Pharmacokinetic Research (CAPKR) at The…

CertaraJuly 24, 2024

Conference

BioTechX Europe 2026

CertaraJuly 23, 2024

Modeling and Simulation – PK/PD

Enhancing Pharmacokinetics Workflows at Charles River

PBPK modeling to support bioequivalence & generic product approvals

Informing pregnancy dose via target-mediated drug disposition modeling and simulations for a recombinant human monoclonal antibody

On-ramps to popPK: Building Better Models with GUI, Code, or Both

Certara University: Grow as a PK/PD Scientist

16th Annual World ADC London 2026

Prediction of CYP-mediated DDIs involving inhibition: Approaches to address the requirements for system qualification of the Simcyp Simulator

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)

A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator

BioTechX Europe 2026

Newsletter sign up

Quick links

Solutions

Contact